Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.
Lab Invest
; 98(11): 1465-1477, 2018 11.
Article
in En
| MEDLINE
| ID: mdl-30143751
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ursodeoxycholic Acid
/
Cholagogues and Choleretics
/
Cholangitis, Sclerosing
/
Mast Cells
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Lab Invest
Year:
2018
Document type:
Article